ESTA Stock Cash Flow Statements

Establishment Labs Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Establishment Labs Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30

cash flows from operating activities:
net income	-16,593,000	-20,710,000	-34,531,000	-16,682,000	-17,181,000	-16,202,000	-29,273,000	-16,745,000	-11,942,000	-13,562,000	-18,608,000	-37,106,000	-5,933,000	-14,191,000	-14,678,000	-5,322,000	-6,948,000	-5,644,000	-4,247,000	-10,471,000	-17,759,000	-12,775,000	-9,040,000	-10,779,000	1,306,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	2,355,000	2,335,000	2,154,000	1,990,000	1,422,000	1,268,000	1,061,000	947,000	936,000	989,000	978,000	950,000	953,000	926,000	948,000	936,000	908,000	846,000	873,000	796,000	833,000	794,000	783,000	633,000	696,000
benefit from credit losses	238,000	1,726,000		613,000	78,000	275,000
benefit from inventory obsolescence	804,000	650,000	1,012,000	275,000	-44,000	562,000	402,000	1,041,000	-387,000	90,000	217,000	-145,000	1,415,000	245,000	116,000	-116,000	93,000	-332,000	948,000	427,000	137,000	-71,000	61,000	-83,000
share-based compensation	3,185,000	2,434,000	3,546,000	3,656,000	3,758,000	3,444,000	3,971,000	3,616,000	3,324,000	3,260,000	2,921,000	3,743,000	3,434,000	3,030,000	3,064,000	2,557,000	1,756,000	1,187,000	1,348,000	1,557,000	1,629,000	1,444,000	1,894,000	1,836,000
loss/(gain) from disposal of property and equipment	-444,000	436,000
unrealized foreign currency (gain)/ loss	-5,971,000	-3,510,000		-2,580,000	2,392,000	2,039,000	3,139,000	-2,051,000	-1,709,000			4,924,000	-2,889,000
amortization of right-to-use asset	241,000	231,000	239,000	198,000	161,000	145,000	183,000	182,000	177,000	158,000	124,000	92,000	95,000	101,000	101,000	103,000	101,000
non-cash loss on contract termination
stock compensation in lieu of cash fees	98,000	110,000	110,000	634,000	110,000	110,000
interest capitalized for construction in progress			0	0	-18,000	-537,000	-1,094,000	-1,125,000	-797,000
non-cash interest expense and amortization of debt discount	793,000	763,000	749,000	629,000	1,546,000	3,447,000	3,351,000				2,711,000														819,000
changes in operating assets and liabilities:
accounts receivable	-4,461,000	775,000	-5,146,000	-6,909,000	-9,615,000	-4,608,000	-4,655,000	-9,623,000	-5,356,000	-2,450,000	-865,000	-3,951,000	-5,067,000	100,000	-2,421,000	844,000	-5,218,000	514,000	-859,000	4,321,000	-171,000	-1,564,000	-832,000	-2,883,000	-2,207,000
inventory	-5,390,000	-10,182,000	-11,337,000	-1,494,000	7,359,000	5,001,000	-13,880,000	-10,584,000	-8,494,000	-2,585,000	-7,351,000	-55,000	-909,000	-2,355,000	-4,212,000	-379,000	-698,000	6,508,000	1,513,000	-3,673,000	438,000	-1,282,000	-2,469,000	1,744,000	-2,339,000
prepaid expenses and other current assets	-946,000	176,000	-261,000	-1,502,000	59,000	1,790,000	-898,000	41,000	-246,000	-1,298,000	-4,103,000	843,000	69,000	1,709,000	-4,443,000	-94,000	1,217,000	87,000	-1,624,000	3,327,000	-660,000	-2,715,000	592,000	-826,000	-2,394,000
other assets	416,000	34,000	33,000	-2,000	-191,000	-323,000	110,000	-122,000	-137,000	187,000	-281,000	-20,000	-636,000	-114,000	163,000	15,000	26,000	-247,000	-34,000			53,000	-45,000	-11,000	786,000
accounts payable	10,031,000	1,354,000	11,047,000	6,625,000	-904,000	-10,097,000	4,999,000	5,157,000	-1,482,000	3,766,000	-769,000	-642,000	2,021,000	4,299,000	354,000	923,000	-617,000	2,357,000	-1,978,000	-1,655,000	366,000	1,270,000	3,032,000	-619,000	-1,973,000
accrued liabilities	-3,392,000	4,038,000	1,898,000	2,501,000	-2,850,000	2,846,000	946,000	-2,395,000	2,236,000	123,000	1,078,000	-161,000	1,775,000	-2,102,000	4,615,000	2,371,000	-158,000	1,383,000	1,730,000	-45,000	40,000	1,255,000	1,567,000	1,142,000	980,000
operating lease liabilities	-240,000	-227,000	-203,000	-149,000	-152,000	-142,000	-174,000	-162,000	-175,000	-127,000	-70,000	-90,000	-91,000	-99,000	-97,000	-117,000	-95,000
other liabilities	-20,000	-1,158,000	1,696,000	-174,000	-119,000	-176,000	49,000	59,000	22,000	274,000	-171,000	195,000	-181,000	457,000	-94,000	1,000	-221,000	484,000	511,000	-24,000	19,000	-151,000	246,000	161,000	-464,000
net cash from operating activities	-18,753,000	-20,725,000	-20,749,000	-12,461,000	-14,154,000	-11,152,000	-31,511,000	-28,240,000	-20,614,000	-14,016,000	-21,980,000	-11,330,000	-4,840,000	-7,709,000	-12,455,000	-814,000	-6,554,000	3,434,000	-3,047,000	-6,095,000	-6,802,000	-10,896,000	-7,063,000	-7,998,000	-10,495,000
capex	-1,624,000	-753,000	-531,000	-1,473,000	-798,000	-3,312,000	-3,704,000	-3,117,000	-432,000	-966,000	-480,000	-607,000	-798,000	242,000	-963,000	-900,000	-804,000	-287,000	-846,000	-603,000	-687,000	-741,000	-4,197,000	-685,000	-561,000
free cash flows	-20,377,000	-21,478,000	-21,280,000	-13,934,000	-14,952,000	-14,464,000	-35,215,000	-31,357,000	-21,046,000	-14,982,000	-22,460,000	-11,937,000	-5,638,000	-7,467,000	-13,418,000	-1,714,000	-7,358,000	3,147,000	-3,893,000	-6,698,000	-7,489,000	-11,637,000	-11,260,000	-8,683,000	-11,056,000
cash flows from investing activities:
purchases of property and equipment	-1,624,000	-753,000	-531,000	-1,473,000	-798,000	-3,312,000	-3,704,000	-3,117,000	-432,000	-966,000	-480,000	-607,000	-798,000	242,000	-963,000	-900,000	-804,000	-287,000	-846,000	-603,000	-687,000	-741,000	-4,197,000	-685,000	-561,000
cash from business acquisitions, net of cash acquired	0	-307,000
cost incurred for intangible assets	-447,000	-276,000	-1,150,000	-1,132,000	-2,872,000	-1,879,000	-244,000	-77,000	-49,000	-282,000	-553,000	-266,000	-390,000	-1,000,000	-120,000	-33,000	-294,000	-837,000	-152,000	-233,000	-262,000	0	-14,000	-3,000	-7,000
capital expenditures on construction in progress			-88,000	-160,000	-731,000	-1,435,000	-2,652,000	-5,855,000	-3,797,000	-9,180,000	-3,777,000	-12,416,000	-4,551,000
net cash from investing activities	-2,071,000	-1,336,000	-1,819,000	-2,765,000	-4,401,000	-6,626,000	-6,600,000	-9,049,000	-4,278,000	-10,428,000	-4,810,000	-13,814,000	-5,739,000	-3,615,000	-1,083,000	-933,000	-1,532,000	-1,124,000	-2,153,000	-1,333,000	-949,000	-741,000	-4,211,000	-1,455,000	-568,000
cash flows from financing activities:
borrowings on short-term notes payable
issuance of common shares, net of underwriters’ discount and issuance costs
proceeds from stock option exercises	273,000	79,000	392,000	59,000	577,000	1,426,000	593,000	210,000	1,271,000	485,000	1,275,000	411,000	1,702,000	487,000	1,681,000	533,000	1,882,000	680,000	192,000	193,000	181,000	102,000	92,000	84,000	180,000
tax payments related to shares withheld upon vesting of restricted stock	-144,000	-282,000	-116,000	-87,000	-188,000	-119,000	-106,000	-282,000	-62,000	1,000				-268,000	-13,000	-34,000	-41,000	-89,000	-17,000	-14,000	-34,000	-44,000	-35,000	-56,000
net cash from financing activities	5,129,000	-203,000	74,491,000	-28,000	389,000	51,043,000	487,000	84,492,000	1,183,000	24,977,000	1,265,000	72,318,000	1,695,000	207,000	1,637,000	422,000	1,786,000	538,000	90,000	116,000	63,926,000	22,466,000	-26,000	-16,000	65,283,000
effect of exchange rate changes on cash and cash equivalents	1,156,000	1,095,000	-1,273,000	351,000	-214,000	-320,000
net increase in cash and cash equivalents	-14,539,000	-21,169,000		-14,903,000	-18,380,000	32,945,000
cash and cash equivalents at beginning of period	0	90,347,000		0	0	40,035,000
cash and cash equivalents at end of period	-14,539,000	69,178,000	50,650,000	-14,903,000	-18,380,000	72,980,000
benefit from doubtful accounts							287,000	143,000	282,000	-282,000	237,000	87,000	69,000	-277,000	355,000	116,000	6,000	-383,000	-213,000	372,000	599,000			112,000	90,000
change in reserve for pp&e impairment							0	0	-341,000
benefit from deferred income taxes
income from disposal of property and equipment					35,000	6,000	-105,000	59,000	288,000	108,000	41,000	21,000	59,000	37,000	70,000	43,000	20,000	18,000	38,000	109,000	5,000	51,000	16,000	8,000
unrealized foreign currency (gain)/loss
loss on extinguishment of debt										0	0
gain from write-off of liability										0
change in fair value of derivative instruments										0	0	-1,099,000	396,000	-191,000	-57,000	-259,000	-230,000	-1,190,000	-879,000	-1,492,000	1,929,000	-235,000	-2,640,000	32,000	-11,420,000
cash from asset acquisitions										0	0			0	0	0	-434,000	0
issuance of common stock, net of underwriters’ discount and issuance costs					0	49,736,000	0
borrowings under oaktree credit agreement, net of debt discount and issuance costs
repayment of madryn debt agreement										0	0
repayments on finance leases									-26,000	-9,000	-5,000	-5,000	-7,000	-12,000	-31,000	-77,000	-55,000
net (decrease)/increase in cash and cash equivalents
cash at beginning of period							0	0	66,355,000	0	0	0	53,415,000	0	0	0	84,523,000	0	0	0	37,655,000	0	0	52,639,000	0
supplemental disclosures:
cash paid for interest							1,418,000	1,422,000	1,360,000	1,179,000	1,171,000	1,306,000	1,707,000	1,745,000	1,745,000	1,727,000	1,710,000	1,749,000	1,749,000	1,730,000	1,734,000	1,468,000	1,322,000	1,402,000	1,345,000
cash paid for income taxes							812,000	780,000	218,000	827,000	453,000	686,000	159,000	223,000	115,000	304,000	10,000	314,000	0	1,000	1,000	55,000	59,000	87,000	0
supplemental disclosures of non-cash investing and financing activities:
unpaid balance for property and equipment							-340,000	95,000	1,514,000	1,097,000	-5,000	-14,000	51,000	-12,000	-34,000	-75,000	143,000	-42,000	-75,000	-68,000	395,000	-82,000	-83,000	705,000	-253,000
unpaid balance for intangible assets
equity consideration in an asset acquisition																						0	0	337,000
equity consideration in a business acquisition
contingent consideration payable related to a business acquisition
consideration payable related to a business acquisition
cashless option exercises														0
cashless warrant exercises
cash payable to settle contract termination
liability to issue shares to settle contract termination
stock compensation in lieu of cash fees to non-employee directors
effect of exchange rate changes on cash							-368,000	132,000	201,000	473,000	-385,000	-571,000	125,000	-91,000	-282,000	181,000	-273,000	244,000	159,000	98,000	-234,000			-35,000	-285,000
net increase in cash							-37,992,000				-25,910,000														53,935,000
cash at end of period							-37,992,000	47,335,000	42,847,000	1,006,000	-25,910,000	46,603,000	44,656,000	-11,208,000	-12,183,000	-1,144,000	77,950,000	3,092,000	-4,951,000	-7,214,000	93,596,000	10,689,000	-11,265,000	43,135,000	53,935,000
amortization of debt discount									3,187,000				580,000	562,000	533,000	505,000	474,000	458,000	435,000	409,000	388,000	325,000	863,000	868,000
net decrease in cash									-23,508,000				-8,759,000											-9,504,000
consideration payable related to asset acquisition													536,000	134,000	-4,000	9,000	407,000		39,000	-478,000	1,257,000	-43,000	20,000	1,257,000
benefit from fixed asset obsolescence
unrealized foreign currency loss										-4,100,000				883,000	3,228,000	-2,941,000	3,030,000	-2,657,000	-604,000	-198,000	5,845,000
change in fair value of contingent consideration																		0	-5,000	141,000	-440,000	-205,000	-137,000	-225,000	694,000
borrowings under oaktree debt agreement, net of debt discount and issuance costs										24,500,000	0
proceeds from issuance of common shares, net of underwriters’ discount and issuance costs																		0	0	0	63,855,000
net (decrease)/increase in cash														-11,208,000	-12,183,000	-1,144,000	-6,573,000	3,092,000	-4,951,000	-7,214,000	55,941,000	10,689,000
inventory acquired in an asset acquisition																		0				0	153,000	1,104,000
issuance of common shares in settlement of contingent consideration
intangible assets acquired in an asset acquisition																		0
cashless option exercise
borrowings under madryn credit agreement, net of issuance costs
cash used to repurchase warrants
proceeds from warrant exercises																						0	0	58,000
assets acquired under finance leases
consideration payable related to asset acquisitions
repayments on capital leases																			-85,000	-63,000	-76,000	-79,000	-83,000	-102,000	-73,000
assets acquired under capital leases																						0	0	69,000	0
issuance of common shares in partial settlement of contingent consideration
cash from asset acquisition																						0	0	-767,000
unrealized foreign currency (gain) loss																						2,823,000	-825,000	892,000
repayments on related-party notes payable
proceeds from issuance of ordinary shares, net of issuance costs																									2,000
proceeds from issuance of common shares, net of underwriters’ discount
deferred equity issuance costs, ipo
bad debt recovery
payments of deferred offering costs
unpaid deferred offering costs
•
write off of deferred offering costs
increase in restricted cash
repayments on short term notes payable
repayments under perceptive credit agreement
shares repurchased
extinguishment of warrants with related party
conversion of related party convertible notes payable into ordinary shares
stock-based compensation
subsidiary
establishment labs, s.a.
motiva usa, llc
jamm technologies, inc.
establishment labs produtos par saude ltda
european distribution center motiva bvba
motiva implants france sas
jen-vault ag
motiva nordica ab

We provide you with 20 years of cash flow statements for Establishment Labs stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Establishment Labs stock. Explore the full financial landscape of Establishment Labs stock with our expertly curated income statements.

The information provided in this report about Establishment Labs stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.